Overview
Orderly Wellness operates a telehealth platform that connects patients with licensed clinicians across all 50 states who can prescribe GLP-1 medications for weight management. Patients complete online consultations and receive prescriptions with home delivery, paying cash on month-to-month or multi-month plans, with care personalized using health data like bloodwork and DNA and including mental health support, nutrition guidance, fitness coaching, and a digital community. The platform acts as a marketplace that partners with independent providers and pharmacies and uses the OrderlyMeds.com Patient Management System to coordinate care. In 2025 the company began manufacturing meds by leasing a 50,000-square-foot facility in Florida, signaling a move to control more of its supply chain while creating jobs, all aimed at making weight-management care accessible and comprehensive.
Work here?Claim your company
Simplify's take
What believers are saying
- OrderlyMeds reported 125,000 customers and over 1 million pounds lost by September 2026.
- The Veo Health deal deepens retention with recurring testing and physician-advisor subscriptions.
- Hillsborough County manufacturing plans signal vertical integration and potential control over supply and quality.
What critics are saying
- FDA warning letter June 8, 2026 flags compounded-GLP-1 marketing and pharmacy claims.
- BBB logged 195 complaints and 13 unanswered cases by October 24, 2026.
- Compounded-GLP-1 enforcement can compress margins and force a product reset after any FDA crackdown.
What makes Orderly Wellness unique
- Nationwide telehealth access spans all 50 states with licensed physicians and cash-pay convenience.
- September 9, 2026 Veo partnership adds biomarkers, DEXA, and coaching around GLP-1 therapy.
- OrderlyMeds blends prescribing, coaching, pharmacy coordination, and manufacturing ambitions under one brand.
Help us improve and share your feedback! Did you find this helpful?